Product categories
Transplantation
Thalassemias
Oncology
Fetal RHD screening NIPT
Hereditary
Cystic fibrosis
Cardiovascular
Male infertility
Rapid aneuploidy analysis
Accessories
Resources
Knowledge hub
Whitepapers
Tools
IFU & certificates
Company
About us
Teams
Career
News & events
Privacy policy
Legal terms
About cookies
Contact
Contact us
Our offices
Support
Distributors
For investors
For distributors
Document portal
Webshop
Knowledge hub
Join us here for a closer look at the news, research and trends shaping the diagnostic landscape.
Subscribe to our latest news & articles
Knowledge hub
Join us here for a closer look at the news, research and trends shaping the diagnostic landscape.
Filter by
All
Transplantation
Thalassemias
Oncology
Fetal RHD screening NIPT
Hereditary
Cystic fibrosis
Cardiovascular
Male infertility
Rapid aneuploidy analysis
Insights
Technology
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Insights
Transplantation
The importance of implementing early diagnostics after hematopoietic stem cell transplantation (HSCT)
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with malignant or non-malignant hematological diseases.
Case study
Thalassemias
How CING of Cyprus transformed their thalassemia testing with NGS
How CING of Cyprus transformed their Thalassemia testing with NGS
Insights
Transplantation
Chimerism monitoring: is there a new gold standard on the horizon?
NGS technology is enabling improved chimerism monitoring, with novel strategies that combine the benefits of STR-PCR and qPCR into a single assay.
Insights
Fetal RHD screening NIPT
Literature review - NIPT for fetal RHD status using an exon 4-based assay
We summarize the findings of three seminal publications that support clinical implementation of the single-exon detection strategy for fetal RHD screening.
Insights
Fetal RHD screening NIPT
RHD screening just got easier: how single exon NIPT testing helps
In RhD-negative mothers, anti-D prophylaxis can be withheld if the fetus is also RhD-negative. Fetal RHD status testing with NIPT is efficient and low risk.
Insights
Fetal RHD screening NIPT
Prevent RhD disease without overtreatment: how NIPT optimizes administration
Non-invasive prenatal testing (NIPT) can help us determine fetal RhD status without a drop of fetal blood. Learn more.
Technology
Thalassemias
Guide to NGS test implementation - simpler, faster, better
This NGS guide addresses frequently asked questions and highlights key factors to consider when adding a new NGS test to your offering.
Insights
Thalassemias
Genetic testing for alpha and beta thalassemia testing just got a lot easier. One patient – one reaction
Next-generation sequencing (NGS) testing can be used for simultaneous analysis of HBA and HBB gene clusters.
Insights
Thalassemias
Alpha- and beta-thalassemia – can one test meet all needs?
Difference between alpha- & beta-thalassemia testing, as well as new technologies to determine thalassemia variants that can reduce turnaround time.
Technology
Thalassemias
The NGS workflow
These are the traditional four steps in an NGS workflow - nucleic acid extraction, library preparation, sequencing, data analysis.
Technology
Thalassemias
NGS testing in clinical practice - what to expect
Staffing requirements, breadth of assay technologies, assessing the impact on workflows
Case study
Transplantation
A new NGS-based method for chimerism monitoring
New, highly sensitive and precise methods for mixed chimerism analytics
Insights
Thalassemias
Challenges in Thalassemia diagnosis
Thalassemia is typically caused by sequence variants in the HBA1, HBA2 or HBB genes.
Product update
Transplantation
Devyser launches first NGS-based test for mixed chimerism
Devyser Chimerism is an NGS library kit which enables both screening and monitoring using a single reaction mix.
Whitepaper
Oncology
Easily identify BRCA1 and BRCA2 genetic mutations
Read more about simple identification of both BRCA1 and BRCA2 genes in the whitepaper
Next 15 Items
1 / 2